Detalhe da pesquisa
1.
RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing.
Nucleic Acids Res
; 52(7): 3971-3988, 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300787
2.
The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL.
Blood
; 141(12): 1425-1441, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36179280
3.
Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis.
Nucleic Acids Res
; 50(14): 8207-8225, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35848924
4.
IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression.
Mol Cancer
; 22(1): 88, 2023 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246217
5.
The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer.
Nucleic Acids Res
; 48(15): 8576-8590, 2020 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32761127
6.
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer.
RNA Biol
; 18(3): 391-403, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32876513
7.
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.
Nucleic Acids Res
; 47(1): 375-390, 2019 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30371874
8.
IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors.
Nucleic Acids Res
; 46(12): 6285-6303, 2018 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29660014
9.
The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family.
Nucleic Acids Res
; 44(8): 3845-64, 2016 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26917013
10.
Stress granules are dispensable for mRNA stabilization during cellular stress.
Nucleic Acids Res
; 43(4): e26, 2015 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488811
11.
The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer.
Semin Cancer Biol
; 29: 3-12, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25068994
12.
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma.
Hepatology
; 59(5): 1900-11, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24395596
13.
Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia.
Cancer Res
; 82(9): 1818-1831, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35259248
14.
HDLBP binds ER-targeted mRNAs by multivalent interactions to promote protein synthesis of transmembrane and secreted proteins.
Nat Commun
; 13(1): 2727, 2022 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585045
15.
Oncogenic Potential of the Dual-Function Protein MEX3A.
Biology (Basel)
; 10(5)2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34067172
16.
Musashi-1-A Stemness RBP for Cancer Therapy?
Biology (Basel)
; 10(5)2021 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34062997
17.
The MicroRNA Landscape of MYCN-Amplified Neuroblastoma.
Front Oncol
; 11: 647737, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34026620
18.
IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer.
Front Mol Biosci
; 8: 632219, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33829040
19.
Finding the mutations that drive resistance.
Elife
; 92020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32408944
20.
Synthetic circular miR-21 RNA decoys enhance tumor suppressor expression and impair tumor growth in mice.
NAR Cancer
; 2(3): zcaa014, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34316687